Systemic Lupus Erythematosus (SLE): Around 70% of people with lupus have this type. It causes acute and chronic inflammation to a number of organs and organ systems. Cutaneous Lupus (lupus skin ...

USA: A recent pilot study, published in the Journal of the American Academy of Dermatology has shown that a combination topical cream containing 5% 5-fluorouracil and 0.005% calcipotriene is ...

Sept 30 (Reuters) - Kezar Life Sciences (KZR.O), opens new tab said on Monday it has paused a trial of its experimental drug for lupus to review safety data after four patients died in the mid ...

a kidney disease-related complication of systemic lupus erythematosus. Patients were dosed with either 30 mg of zetomipzomib, 60 mg of zetomipzomib or placebo and standard background therapy.

The Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) drugs in development market research report provides comprehensive information on the therapeutics under ...

Systemic lupus erythematosus (SLE) and inflammatory bowel disease (IBD, a group of intestinal disorders that cause inflammation of the digestive tract) share a common set of microbiome features that ...

The drug is being tested in patients with the most common form of lupus, systemic lupus erythematosus, where the patient's immune system attacks the body's own tissues and potentially leads to ...

Surgery was the most effective treatment for lesion and participant recurrence and clearance rates among patients with cutaneous squamous cell carcinoma ... each outcome was conducted with a ...

Cullinan Therapeutics has filed an investigational new drug application with the U.S. Food and Drug Administration (FDA) for CLN-978 for the treatment of systemic lupus erythematosus (SLE). Continue ...

Others causes are related to an underlying disease process like infection, cancer, or an autoimmune disorder, such as lupus. The pleura is actually a membrane that contains two thin membranes—one that ...